Alamar Biosciences, Inc. (California) (ALMR)

27.79 +2.42 (+9.54%) USD  |  NASDAQ  |  Oct 15, 12:57
More

Alamar Biosciences Total Long Term Debt (Quarterly) : 49.13M for June 30, 2026

Total Long Term Debt (Quarterly) Chart

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
June 30, 2026 49.13M
March 31, 2026 338.95M
Date Value
June 30, 2025 0.00
March 31, 2025 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Personalis, Inc. 31.06M
10X Genomics, Inc. 66.78M
Adaptive Biotechnologies Corp. 401.68M
Champions Oncology, Inc. 10.34M
Medpace Holdings, Inc. 120.10M